Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS
Ra Capital Management, L.P. reported a 24.80% stake in Acumen Pharmaceuticals, Inc. (Schedule 13D/A)
Event Mar 27, 2025 · Filed Mar 31, 2025
Ra Capital Management, L.P. reported a 24.80% stake in Acumen Pharmaceuticals, Inc., 15,016,063 shares, with active intent on Mar 27, 2025. Filed Mar 31, 2025 (Schedule 13D/A).
- Stake
- 24.80%
- Shares
- 15,016,063
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 24.80% | 15,016,063 |
| Peter Kolchinsky | 24.80% | 15,016,063 |
| Rajeev Shah | 24.80% | 15,016,063 |
| RA Capital Healthcare Fund, L.P. | 21.50% | 13,043,179 |
Source
Related
- Acumen Pharmaceuticals, Inc.
- Ra Capital Management, L.P.
- Acumen Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Mar 17, 2026
- Form 4 · Porter Derrell · Jun 17, 2026
- Form 4 · Fountain Nathan B · Jun 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 5, 2026
- Form 4 · Fountain Nathan B · Jun 5, 2026
- Form 4 · Drapkin Kimberlee C · Jun 5, 2026